This symposium, which took place on 1st December 2022 as part of the European Academy of Allergy and Clinical Immunology (EAACI) FAAM-EUROBAT Digital Conference presented new evidence on the role of human milk oligosaccharides (2 fucosyllactose and lacto-N-neotetraose) in supporting development of the infant microbiota, modulating the immune system, and ultimately improving the clinical management of cow’s milk protein allergy.
EMJ Allergy & Immunology 8 [Supplement 1] . 2023
January 2023
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given